Lifestyle Intervention for Cardiovascular Disease and Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on lifestyle changes, so it's best to discuss your medications with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment for cardiovascular disease and type 2 diabetes?
Research shows that family-based interventions, especially those culturally tailored, can improve self-management and reduce distress in individuals with type 2 diabetes. These interventions have shown sustained improvements in diet and exercise management, which are crucial for managing diabetes and potentially beneficial for cardiovascular health.12345
Is the lifestyle intervention for cardiovascular disease and type 2 diabetes safe for humans?
How is the Family Dyad Intervention treatment different from other treatments for cardiovascular disease and type 2 diabetes?
The Family Dyad Intervention is unique because it involves the patient's family in the treatment process, focusing on family engagement, empowerment, and support to improve lifestyle habits and manage health conditions. This approach is culturally tailored and emphasizes the role of family dynamics in promoting health, which is different from traditional individual-focused treatments.12378
What is the purpose of this trial?
Rural populations in the U.S. are disproportionately burdened by cardiovascular disease and type 2 diabetes. Lifestyle modification interventions are needed that support long-term engagement in risk-reducing health behaviors. This trial will study the effects of a family-focused, lifestyle intervention that is culturally tailored for use with rural Hispanic and non-Hispanic adults. If successful, this community-based intervention has significant potential for broad dissemination to reduce cardiovascular disease and type 2 diabetes health disparities in rural U.S. communities.
Research Team
Gia Mudd, RN, PhD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for adults over 18 living in rural Kentucky, with internet access and at risk for type 2 diabetes or cardiovascular disease. Participants must speak English or Spanish and may include a family member who lives nearby. Those with cognitive impairments, major psychiatric conditions, pregnancy, or known heart diseases are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive eight weekly educational sessions focused on self-management of risk factors and engagement in healthy behaviors for risk reduction
Follow-up
Community health workers follow up with participants once a month by phone to monitor long-term impact on type 2 diabetes and CVD risk factors
Treatment Details
Interventions
- Active Control Intervention educational sessions
- Family Dyad Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Gia Mudd
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator